Cellular and molecular mechanisms underlying obesity in degenerative spine and joint diseases

Abstract

Degenerative spine and joint diseases, including intervertebral disc degeneration (IDD), ossification of the spinal ligaments (OSL), and osteoarthritis (OA), are common musculoskeletal diseases that cause pain or disability to the patients. However, the pathogenesis of these musculoskeletal disorders is complex and has not been elucidated clearly to date. As a matter of fact, the spine and joints are not independent of other organs and tissues. Recently, accumulating evidence demonstrates the association between obesity and degenerative musculoskeletal diseases. Obesity is a common metabolic disease characterized by excessive adipose tissue or abnormal adipose distribution in the body. Excessive mechanical stress is regarded as a critical risk factor for obesity-related pathology. Additionally, obesity-related factors, mainly including lipid metabolism disorder, dysregulated pro-inflammatory adipokines and cytokines, are reported as plausible links between obesity and various human diseases. Importantly, these obesity-related factors are deeply involved in the regulation of cell phenotypes and cell fates, extracellular matrix (ECM) metabolism, and inflammation in the pathophysiological processes of degenerative spine and joint diseases. In this study, we systematically discuss the potential cellular and molecular mechanisms underlying obesity in these degenerative musculoskeletal diseases, and hope to provide novel insights for developing targeted therapeutic strategies.

References

[1] Buchbinder R, et al.. Low back pain: a call for action. Lancet, 2018, 391: 2384-2388

[2] Fehlings MG, et al.. The aging of the global population: the changing epidemiology of disease and spinal disorders. Neurosurgery, 2015, 77: S1-S5

[3] Fine N, et al.. Intervertebral disc degeneration and osteoarthritis: a common molecular disease spectrum. Nat. Rev. Rheumatol., 2023, 19: 136-152

[4] Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet, 2019, 393: 1745-1759

[5] Binch ALA, Fitzgerald JC, Growney EA, Barry F. Cell-based strategies for IVD repair: clinical progress and translational obstacles. Nat. Rev. Rheumatol., 2021, 17: 158-175

[6] Yang S, Zhang F, Ma J, Ding W. Intervertebral disc ageing and degeneration: The antiapoptotic effect of oestrogen. Ageing Res. Rev., 2020, 57: 100978

[7] Xiang Q, Zhao Y, Lin J, Jiang S, Li W. The Nrf2 antioxidant defense system in intervertebral disc degeneration: Molecular insights. Exp. Mol. Med, 2022, 54: 1067-1075

[8] Xiang Q, Zhao Y, Lin J, Jiang S, Li W. Epigenetic modifications in spinal ligament aging. Ageing Res Rev., 2022, 77: 101598

[9] Sampath SJP, Venkatesan V, Ghosh S, Kotikalapudi N. Obesity, metabolic syndrome, and osteoarthritis-an updated review. Curr. Obes. Rep., 2023, 12: 308-331

[10] Fan D, Chen Z, Chen Y, Shang Y. Mechanistic roles of leptin in osteogenic stimulation in thoracic ligament flavum cells. J. Biol. Chem., 2007, 282: 29958-29966

[11] Francisco V, et al.. A new immunometabolic perspective of intervertebral disc degeneration. Nat. Rev. Rheumatol., 2022, 18: 47-60

[12] Segar AH, et al.. Obesity increases the odds of intervertebral disc herniation and spinal stenosis; an MRI study of 1634 low back pain patients. Eur. Spine J., 2024, 33: 915-923

[13] Afshin A, et al.. Health effects of overweight and obesity in 195 countries over 25 years. N. Engl. J. Med., 2017, 377: 13-27

[14] Singh, N. K., Singh, N. K., Verma, R. & Diwan, A. D. Validation and estimation of obesity-induced intervertebral disc degeneration through subject-specific finite element modelling of functional spinal units. Bioengineering 11, 344 (2024).

[15] Chen L, et al.. Pathogenesis and clinical management of obesity-related knee osteoarthritis: Impact of mechanical loading. J. Orthop. Transl., 2020, 24: 66-75

[16] Lopez-Yus, M., Hörndler, C., Borlan, S., Bernal-Monterde, V. & Arbones-Mainar, J. M. Unraveling adipose tissue dysfunction: molecular mechanisms, novel biomarkers, and therapeutic targets for liver fat deposition. Cells 13, 5 (2024).

[17] Nussbaumerova B, Rosolova H. Obesity and dyslipidemia. Curr. Atheroscler. Rep., 2023, 25: 947-955

[18] He Y, et al.. Roles of organokines in intervertebral disc homeostasis and degeneration. Front. Endocrinol., 2024, 15: 1340625

[19] Sampara P, Banala RR, Vemuri SK, Av GR, Gpv S. Understanding the molecular biology of intervertebral disc degeneration and potential gene therapy strategies for regeneration: a review. Gene Ther., 2018, 25: 67-82

[20] Lyu FJ, et al.. Painful intervertebral disc degeneration and inflammation: from laboratory evidence to clinical interventions. Bone Res., 2021, 9: 7

[21] Sakai D, Grad S. Advancing the cellular and molecular therapy for intervertebral disc disease. Adv. Drug Deliv. Rev., 2015, 84: 159-171

[22] Liu J, et al.. Identification of CXCL16 as a diagnostic biomarker for obesity and intervertebral disc degeneration based on machine learning. Sci. Rep., 2023, 13 21316

[23] Ambrosio, L. et al. The burden of low back pain in children and adolescents with overweight and obesity: from pathophysiology to prevention and treatment strategies. Ther. Adv. Musculoskelet. Disease 15, 1759720X231188831 (2023).

[24] Ranson WA, et al.. Risk factors for perioperative complications in morbidly obese patients undergoing elective posterior lumbar fusion. Glob. Spine J., 2018, 8: 795-802

[25] Lener S, Wipplinger C, Hartmann S, Thomé C, Tschugg A. The impact of obesity and smoking on young individuals suffering from lumbar disc herniation: a retrospective analysis of 97 cases. Neurosurg. Rev., 2020, 43: 1297-1303

[26] Coppock JA, et al.. Increasing BMI increases lumbar intervertebral disc deformation following a treadmill walking stress test. J. Biomech., 2021, 121: 110392

[27] Adams MA, Roughley PJ. What is intervertebral disc degeneration, and what causes it?. Spine, 2006, 31: 2151-2161

[28] Wilke HJ, Neef P, Caimi M, Hoogland T, Claes LE. New in vivo measurements of pressures in the intervertebral disc in daily life. Spine, 1999, 24: 755-762

[29] Yan Z, et al.. Static compression induces ECM remodeling and integrin α2β1 expression and signaling in a rat tail caudal intervertebral disc degeneration model. Spine, 2017, 42: E448-e458,

[30] Xiang Q, et al.. CircRNA-CIDN mitigated compression loading-induced damage in human nucleus pulposus cells via miR-34a-5p/SIRT1 axis. EBioMedicine, 2020, 53: 102679

[31] Ariga K, et al.. Mechanical stress-induced apoptosis of endplate chondrocytes in organ-cultured mouse intervertebral discs: an ex vivo study. Spine, 2003, 28: 1528-1533

[32] Xu HG, et al.. Intermittent cyclic mechanical tension promotes endplate cartilage degeneration via canonical Wnt signaling pathway and E-cadherin/β-catenin complex cross-talk. Osteoarthr. Cartil., 2016, 24: 158-168

[33] Wang Z, et al.. Mechanical factors regulate annulus fibrosus (AF) injury repair and remodeling: a review. ACS Biomater. Sci. Eng., 2024, 10: 219-233

[34] Zhang Y, et al.. Positional cloning of the mouse obese gene and its human homologue. Nature, 1994, 372: 425-432

[35] Zhao CQ, Liu D, Li H, Jiang LS, Dai LY. Expression of leptin and its functional receptor on disc cells: contribution to cell proliferation. Spine, 2008, 33: E858-864,

[36] Miao D, Zhang L. Leptin modulates the expression of catabolic genes in rat nucleus pulposus cells through the mitogen-activated protein kinase and Janus kinase 2/signal transducer and activator of transcription 3 pathways. Mol. Med. Rep., 2015, 12: 1761-1768

[37] Ding W, et al.. Leptin induces terminal differentiation of rat annulus fibrosus cells via activation of MAPK signaling. Anat. Rec., 2013, 296: 1806-1812

[38] Han YC, et al.. Leptin regulates disc cartilage endplate degeneration and ossification through activation of the MAPK-ERK signalling pathway in vivo and in vitro. J. Cell Mol. Med., 2018, 22: 2098-2109

[39] Natelson DM, et al.. Leptin signaling and the intervertebral disc: Sex dependent effects of leptin receptor deficiency and Western diet on the spine in a type 2 diabetes mouse model. PLoS One, 2020, 15: e0227527

[40] Li X, et al.. Intervertebral disc degeneration in mice with type II diabetes induced by leptin receptor deficiency. BMC Musculoskelet. Disord., 2020, 21 77

[41] Berndt J, et al.. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes, 2005, 54: 2911-2916

[42] Zahorska-Markiewicz B, et al.. Serum concentration of visfatin in obese women. Metab. Clin. Exp., 2007, 56: 1131-1134

[43] Cui H, et al.. Visfatin promotes intervertebral disc degeneration by inducing IL-6 expression through the ERK/JNK/p38 signalling pathways. Adipocyte, 2021, 10: 201-215

[44] Huang Y, et al.. Nicotinamide phosphoribosyl transferase controls NLRP3 inflammasome activity through MAPK and NF-κB Signaling in nucleus pulposus cells, as suppressed by melatonin. Inflammation, 2020, 43: 796-809

[45] Shin JH, Park S, Cho H, Kim JH, Choi H. Adipokine human Resistin promotes obesity-associated inflammatory intervertebral disc degeneration via pro-inflammatory cytokine cascade activation. Sci. Rep., 2022, 12 8936

[46] Liu C, et al.. Resistin promotes intervertebral disc degeneration by upregulation of ADAMTS-5 Through p38 MAPK signaling pathway. Spine, 2016, 41: 1414-1420

[47] Li Z, et al.. Resistin promotes CCL4 expression through toll-like receptor-4 and activation of the p38-MAPK and NF-κB signaling pathways: implications for intervertebral disc degeneration. Osteoarthr. Cartil., 2017, 25: 341-350

[48] Hu S, et al.. Chemerin facilitates intervertebral disc degeneration via TLR4 and CMKLR1 and activation of NF-kB signaling pathway. Aging, 2020, 12: 11732-11753

[49] Terashima Y, et al.. Expression of adiponectin receptors in human and rat intervertebral disc cells and changes in receptor expression during disc degeneration using a rat tail temporary static compression model. J. Orthop. Surg. Res., 2016, 11: 147

[50] Yuan B, et al.. Adiponectin downregulates TNF-α expression in degenerated intervertebral discs. Spine, 2018, 43: E381-e389,

[51] Ohnishi, H. et al. Anti-inflammatory effects of adiponectin receptor agonist AdipoRon against intervertebral disc degeneration. Int. J. Mol. Sci. 24, 8566 (2023).

[52] González-Rodríguez, M. et al. Progranulin in musculoskeletal inflammatory and degenerative disorders, focus on rheumatoid arthritis, lupus and intervertebral disc disease: a systematic review. Pharmaceuticals 15, 15544 (2022).

[53] Zhao YP, et al.. Progranulin knockout accelerates intervertebral disc degeneration in aging mice. Sci. Rep., 2015, 5 9102

[54] Wang S, et al.. Progranulin is positively associated with intervertebral disc degeneration by interaction with IL-10 and IL-17 Through TNF Pathways. Inflammation, 2018, 41: 1852-1863

[55] Cabral VLF, et al.. Omentin-1 promoted proliferation and ameliorated inflammation, apoptosis, and degeneration in human nucleus pulposus cells. Arch. Gerontol. Geriatr., 2022, 102: 104748

[56] Huang X, Chen C, Chen Y, Xu J, Liu L. Omentin-1 alleviate interleukin-1β(IL-1β)-induced nucleus pulposus cells senescence. Bioengineered, 2022, 13: 13849-13859

[57] Li X, et al.. Possible involvement of the oxLDL/LOX-1 system in the pathogenesis and progression of human intervertebral disc degeneration or herniation. Sci. Rep., 2017, 7 7403

[58] Zhang X, et al.. Obesity mediates apoptosis and extracellular matrix metabolic imbalances via MAPK pathway activation in intervertebral disk degeneration. Front Physiol., 2019, 10: 1284

[59] Kauppila LI. Atherosclerosis and disc degeneration/low-back pain-a systematic review. Eur. J. Vasc. Endovasc. Surg., 2009, 37: 661-670

[60] Ruiz-Fernández, C. et al. Molecular relationships among obesity, inflammation and intervertebral disc degeneration: are adipokines the Common Link? Int. J. Mol. Sci. 20, 2030 (2019).

[61] Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest., 2007, 117: 175-184

[62] Risbud MV, Shapiro IM. Role of cytokines in intervertebral disc degeneration: pain and disc content. Nat. Rev. Rheumatol., 2014, 10: 44-56

[63] Hoyland JA, Le Maitre C, Freemont AJ. Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc. Rheumatology, 2008, 47: 809-814

[64] Chaput CD, Siddiqui M, Rahm MD. Obesity and calcification of the ligaments of the spine: a comprehensive CT analysis of the entire spine in a random trauma population. Spine J., 2019, 19: 1346-1353

[65] Endo T, et al.. Association between obesity and ossification of spinal ligaments in 622 asymptomatic subjects: a cross-sectional study. J. Bone Miner. Metab., 2022, 40: 337-347

[66] Endo T, et al.. Aggravation of ossified ligamentum flavum lesion is associated with the degree of obesity. Glob. Spine J., 2023, 13: 1325-1331

[67] Endo, T. et al. Strong relationship between dyslipidemia and the ectopic ossification of the spinal ligaments. Sci. Rep. 12, 22617 (2022).

[68] Lin J, et al.. Significance of body mass index on thoracic ossification of the ligamentum flavum in Chinese population. Eur. Spine J., 2022, 31: 3308-3315

[69] Zhao Y, Xiang Q, Lin J, Jiang S, Li W. High body mass index is associated with an increased risk of the onset and severity of ossification of spinal ligaments. Front. Surg., 2022, 9: 941672

[70] Mori K, et al.. Impact of obesity on cervical ossification of the posterior longitudinal ligament: a nationwide prospective study. Sci. Rep., 2022, 12 8884

[71] Fujita N, et al.. Potential involvement of obesity-associated chronic inflammation in the pathogenesis of idiopathic spinal epidural lipomatosis. Spine, 2016, 41: E1402-e1407

[72] Park HK, Ahima RS. Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism. Metab. Clin. Exp., 2015, 64: 24-34

[73] Segar AH, Fairbank JCT, Urban J. Leptin and the intervertebral disc: a biochemical link exists between obesity, intervertebral disc degeneration and low back pain-an in vitro study in a bovine model. Eur. Spine J., 2019, 28: 214-223

[74] De Luca C, et al.. Complete rescue of obesity, diabetes, and infertility in db/db mice by neuron-specific LEPR-B transgenes. J. Clin. Investig., 2005, 115: 3484-3493

[75] Hess R, Pino AM, Ríos S, Fernández M, Rodríguez JP. High affinity leptin receptors are present in human mesenchymal stem cells (MSCs) derived from control and osteoporotic donors. J. Cell. Biochem., 2005, 94: 50-57

[76] Liu X, et al.. Low concentration flufenamic acid enhances osteogenic differentiation of mesenchymal stem cells and suppresses bone loss by inhibition of the NF-κB signaling pathway. Stem Cell Res. Ther., 2019, 10: 213

[77] Ikeda Y, et al.. Association between serum leptin and bone metabolic markers, and the development of heterotopic ossification of the spinal ligament in female patients with ossification of the posterior longitudinal ligament. Eur. Spine J., 2011, 20: 1450-1458

[78] Li Z, et al.. The role of leptin on the organization and expression of cytoskeleton elements in nucleus pulposus cells. J. Orthop. Res., 2013, 31: 847-857

[79] Adeghate E. An update on the biology and physiology of resistin. Cell. Mol. Life Sci., 2004, 61: 2485-2496

[80] Zhao CW, et al.. An update on the emerging role of resistin on the pathogenesis of osteoarthritis. Med. Inflamm., 2019, 2019: 1532164

[81] Sánchez-Duffhues G, Hiepen C, Knaus P, Ten Dijke P. Bone morphogenetic protein signaling in bone homeostasis. Bone, 2015, 80: 43-59

[82] Shang J, et al.. Resistin targets TAZ to promote osteogenic differentiation through PI3K/AKT/mTOR pathway. iScience, 2023, 26: 107025

[83] Yan QW, et al.. The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes, 2007, 56: 2533-2540

[84] Mosialou I, et al.. MC4R-dependent suppression of appetite by bone-derived lipocalin 2. Nature, 2017, 543: 385-390

[85] Loid P, Hauta-Alus H, Mäkitie O, Magnusson P, Mäkitie RE. Lipocalin-2 is associated with FGF23 in WNT1 and PLS3 osteoporosis. Front Endocrinol., 2022, 13: 954730

[86] Courbon G, et al.. Lipocalin 2 stimulates bone fibroblast growth factor 23 production in chronic kidney disease. Bone Res, 2021, 9: 35

[87] Rucci N, et al.. Lipocalin 2: a new mechanoresponding gene regulating bone homeostasis. J. Bone Miner. Res., 2015, 30: 357-368

[88] Garten A, et al.. Physiological and pathophysiological roles of NAMPT and NAD metabolism. Nat. Rev. Endocrinol., 2015, 11: 535-546

[89] He X, et al.. Nicotinamide phosphoribosyltransferase (Nampt) may serve as the marker for osteoblast differentiation of bone marrow-derived mesenchymal stem cells. Exp. Cell Res., 2017, 352: 45-52

[90] Li Y, He J, He X, Li Y, Lindgren U. Nampt expression increases during osteogenic differentiation of multi- and omnipotent progenitors. Biochem. Biophys. Res Commun., 2013, 434: 117-123

[91] Ling M, et al.. Epigenetic regulation of Runx2 transcription and osteoblast differentiation by nicotinamide phosphoribosyltransferase. Cell Biosci., 2017, 7: 27

[92] Kouri FM, et al.. miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma. Genes Dev., 2015, 29: 732-745

[93] Zhang Q, et al.. Overexpression of miR-182 inhibits ossification of ligamentum flavum cells by targeting NAMPT. Exp. Cell Res., 2018, 367: 119-131

[94] Albanese, I., Khan, K., Barratt, B., Al-Kindi, H. & Schwertani, A. Atherosclerotic calcification: Wnt is the hint. J. Am. Heart Assoc. 7, e007356 (2018).

[95] Karner CM, Long F. Wnt signaling and cellular metabolism in osteoblasts. Cell. Mol. Life Sci., 2017, 74: 1649-1657

[96] Alekos NS, Moorer MC, Riddle RC. Dual effects of lipid metabolism on osteoblast function. Front Endocrinol., 2020, 11: 578194

[97] Wu S, De Luca F. Role of cholesterol in the regulation of growth plate chondrogenesis and longitudinal bone growth. J. Biol. Chem., 2004, 279: 4642-4647

[98] Tsezou A, Iliopoulos D, Malizos KN, Simopoulou T. Impaired expression of genes regulating cholesterol efflux in human osteoarthritic chondrocytes. J. Orthop. Res., 2010, 28: 1033-1039

[99] Wang Q, et al.. Fermentation supernatant of Staphylococcus aureus drives catabolism in chondrocytes via NF-κB signaling mediated increase of cholesterol metabolism. Exp. Cell Res., 2022, 410: 112952

[100] Wang X, et al.. Ultrasound-targeted simvastatin-loaded microbubble destruction promotes OA cartilage repair by modulating the cholesterol efflux pathway mediated by PPARγ in rabbits. Bone Jt. Res., 2021, 10: 693-703

[101] Parhami F, et al.. Role of the cholesterol biosynthetic pathway in osteoblastic differentiation of marrow stromal cells. J. Bone Miner. Res., 2002, 17: 1997-2003

[102] Sheng R, et al.. Cholesterol selectively activates canonical Wnt signalling over non-canonical Wnt signalling. Nat. Commun., 2014, 5 4393

[103] Li K, et al.. A dual role of cholesterol in osteogenic differentiation of bone marrow stromal cells. J. Cell. Physiol., 2019, 234: 2058-2066

[104] Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene, 1999, 18: 6853-6866

[105] Liu L, et al.. Oxidized low-density lipoprotein and β-glycerophosphate synergistically induce endothelial progenitor cell ossification. Acta Pharmacol. Sin., 2011, 32: 1491-1497

[106] Dawodu D, Patecki M, Dumler I, Haller H, Kiyan Y. oxLDL inhibits differentiation of mesenchymal stem cells into osteoblasts via the CD36 mediated suppression of Wnt signaling pathway. Mol. Biol. Rep., 2019, 46: 3487-3496

[107] Long F. Building strong bones: molecular regulation of the osteoblast lineage. Nat. Rev. Mol. cell Biol., 2011, 13: 27-38

[108] Frey JL, et al.. Wnt-Lrp5 signaling regulates fatty acid metabolism in the osteoblast. Mol. Cell. Biol., 2015, 35: 1979-1991

[109] Nile AH, Hannoush RN. Fatty acid recognition in the Frizzled receptor family. J. Biol. Chem., 2019, 294: 726-736

[110] Takada R, et al.. Monounsaturated fatty acid modification of wnt protein: its role in wnt secretion. Dev. Cell, 2006, 11: 791-801

[111] Lee WC, Guntur AR, Long F, Rosen CJ. Energy metabolism of the osteoblast: implications for osteoporosis. Endocr. Rev., 2017, 38: 255-266

[112] Wu X, Fan X, Crawford R, Xiao Y, Prasadam I. The metabolic landscape in osteoarthritis. Aging Dis., 2022, 13: 1166-1182

[113] Tsai YW, et al.. Palmitoleic acid ameliorates palmitic acid-induced proinflammation in J774A.1 macrophages via TLR4-dependent and TNF-α-independent signallings. Prostaglandins, Leukotrienes, Essent. Fat. Acids, 2021, 169: 102270

[114] Ren L, et al.. The roles of inflammatory cytokines in the pathogenesis of ossification of ligamentum flavum. Am. J. Transl. Res., 2013, 5: 582-585

[115] Sims NA. Influences of the IL-6 cytokine family on bone structure and function. Cytokine, 2021, 146: 155655

[116] Yeh LC, Ford JJ, Lee JC, Adamo ML. Palmitate attenuates osteoblast differentiation of fetal rat calvarial cells. Biochem. Biophys. Res. Commun., 2014, 450: 777-781

[117] Qian G, Fan W, Ahlemeyer B, Karnati S, Baumgart-Vogt E. Peroxisomes in different skeletal cell types during intramembranous and endochondral ossification and their regulation during osteoblast differentiation by distinct peroxisome proliferator-activated receptors. PLoS One, 2015, 10: e0143439

[118] Harasymowicz NS, Dicks A, Wu CL, Guilak F. Physiologic and pathologic effects of dietary free fatty acids on cells of the joint. Ann. N. Y. Acad. Sci., 2019, 1440: 36-53

[119] Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes. Rev., 2009, 11: 11-18

[120] Zhao Y, et al.. High systemic immune-inflammation index and body mass index are independent risk factors of the thoracic ossification of the ligamentum flavum. Med. Inflamm., 2022, 2022: 1-7

[121] Dou X, et al.. Fibrotic and inflammatory characteristics of epidural fat adjacent to the ossification area in patients with ossification of the ligament flavum. JOR Spine, 2022, 5: e1229

[122] Park JO, et al.. Inflammatory cytokines induce fibrosis and ossification of human ligamentum flavum cells. J. Spinal Disord. Tech., 2013, 26: E6-12,

[123] Qu X, et al.. M1 macrophage-derived interleukin-6 promotes the osteogenic differentiation of ligamentum flavum cells. Spine, 2022, 47: E527-E535

[124] Huang AY, Shu L, Chen Z, Zhang C. IL-6 is involved in thoracic ossification of the ligamentum flavum. PLoS One, 2022, 17: e0272357

[125] Manolagas SC. The role of IL-6 type cytokines and their receptors in bone. Ann. N. Y. Acad. Sci., 1998, 840: 194-204

[126] Ono T, et al.. IL-17-producing γδ T cells enhance bone regeneration. Nat. Commun., 2016, 7 10928

[127] Nam D, et al.. T-lymphocytes enable osteoblast maturation via IL-17F during the early phase of fracture repair. PLoS One, 2012, 7: e40044

[128] Kim YG, et al.. IL-17 inhibits osteoblast differentiation and bone regeneration in rat. Arch. Oral. Biol., 2014, 59: 897-905

[129] Shaw AT, Maeda Y, Gravallese EM. IL-17A deficiency promotes periosteal bone formation in a model of inflammatory arthritis. Arthritis Res. Ther., 2016, 18: 104

[130] Lin J, et al.. Interleukin-17A promotes proliferation and osteogenic differentiation of human ligamentum flavum cells through regulation of β-catenin signaling. Spine, 2023, 48: E362-e371

[131] Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat. Rev. Immunol., 2003, 3: 745-756

[132] Gerstenfeld LC, et al.. Impaired fracture healing in the absence of TNF-alpha signaling: the role of TNF-alpha in endochondral cartilage resorption. J. Bone Miner. Res., 2003, 18: 1584-1592

[133] Zhang C, et al.. The involvement and possible mechanism of pro-inflammatory tumor necrosis factor alpha (TNF-α) in thoracic ossification of the ligamentum flavum. PLoS One, 2017, 12: e0178986

[134] Wang B, et al.. iTRAQ quantitative proteomic study in patients with thoracic ossification of the ligamentum flavum. Biochem. Biophys. Res. Commun., 2017, 487: 834-839

[135] Zhang X, et al.. Telmisartan mitigates TNF-α-Induced Type II collagen reduction by upregulating SOX-9. ACS Omega, 2021, 6: 11756-11761

[136] Xu Z, Ke T, Zhang Y, Fu C, He W. Agonism of GPR120 prevented IL-1β-induced reduction of extracellular matrix through SOX-9. Aging (Albany NY), 2020, 12: 12074-12085

[137] Fukada S, et al.. Dyslipidemia as a novel risk for the development of symptomatic ossification of the posterior longitudinal ligament. Spine J., 2023, 23: 1287-1295

[138] Feng B, et al.. Roles and mechanisms of leptin in osteogenic stimulation in cervical ossification of the posterior longitudinal ligament. J. Orthop. Surg. Res., 2018, 13: 165

[139] Chen S, et al.. Combined use of leptin and mechanical stress has osteogenic effects on ossification of the posterior longitudinal ligament. Eur. Spine J., 2018, 27: 1757-1766

[140] Fay, L. Y. et al. Comparative study of the cytokine profiles of serum and tissues from patients with the ossification of the posterior longitudinal ligament. Biomedicines 11, 2021 (2023).

[141] Wang L, et al.. Could heterotopic ossification be prevented by varying dietary n-3/n-6 polyunsaturated fatty acid ratio: a novel perspective to its treatment?. Med. Hypotheses, 2013, 80: 57-60

[142] Hamazaki K, et al.. Mead acid (20:3n-9) and n-3 polyunsaturated fatty acids are not associated with risk of posterior longitudinal ligament ossification: results of a case-control study. Prostaglandins, leukotrienes, Essent. Fat. Acids, 2015, 96: 31-36

[143] Yan T, Liu H, Lin L, Zhang ZJJOSU. Effects of TNF-α on cultured spinal ligament cells in vitro. J. Shandong Univ. (Health Sciences), 2009, 47: 93-100

[144] Ji N, Yu Z. IL-6/Stat3 suppresses osteogenic differentiation in ossification of the posterior longitudinal ligament via miR-135b-mediated BMPER reduction. Cell Tissue Res., 2023, 391: 145-157

[145] Kraus VB, Blanco FJ, Englund M, Karsdal MA, Lohmander LS. Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use. Osteoarthr. Cartil., 2015, 23: 1233-1241

[146] Anderson JJ, Felson DT. Factors associated with osteoarthritis of the knee in the first national Health and Nutrition Examination Survey (HANES I). Evidence for an association with overweight, race, and physical demands of work. Am. J. Epidemiol., 1988, 128: 179-189

[147] Lee R, Kean WF. Obesity and knee osteoarthritis. Inflammopharmacology, 2012, 20: 53-58

[148] Nishimura A, et al.. Risk factors for the incidence and progression of radiographic osteoarthritis of the knee among Japanese. Int. Orthop., 2011, 35: 839-843

[149] Cooper C, et al.. Risk factors for the incidence and progression of radiographic knee osteoarthritis. Arthritis Rheum., 2000, 43: 995-1000

[150] Wallace IJ, et al.. Knee osteoarthritis has doubled in prevalence since the mid-20th century. Proc. Natl. Acad. Sci. USA, 2017, 114: 9332-9336

[151] Coggon D, et al.. Knee osteoarthritis and obesity. Int. J. Obes. Relat. Metab. Disord., 2001, 25: 622-627

[152] Losina E, et al.. Lifetime risk and age at diagnosis of symptomatic knee osteoarthritis in the US. Arthritis Care Res., 2013, 65: 703-711

[153] Issa, R. I. & Griffin, T. M. Pathobiology of obesity and osteoarthritis: integrating biomechanics and inflammation. Pathobiol. Aging Age Related Diseases 2, https://doi.org/10.3402/pba.v2i0.17470 (2012).

[154] Courties A, Sellam J, Berenbaum F. Metabolic syndrome-associated osteoarthritis. Curr. Opin. Rheumatol., 2017, 29: 214-222

[155] Thijssen E, van Caam A, van der Kraan PM. Obesity and osteoarthritis, more than just wear and tear: pivotal roles for inflamed adipose tissue and dyslipidaemia in obesity-induced osteoarthritis. Rheumatology, 2015, 54: 588-600

[156] Belluzzi E, et al.. Systemic and local adipose tissue in knee osteoarthritis. J. Cell. Physiol., 2017, 232: 1971-1978

[157] Urban H, Little CB. The role of fat and inflammation in the pathogenesis and management of osteoarthritis. Rheumatology, 2018, 57: iv10-iv21

[158] Wang T, He C. Pro-inflammatory cytokines: The link between obesity and osteoarthritis. Cytokine Growth Factor Rev., 2018, 44: 38-50

[159] Sun AR, et al.. Cartilage tissue engineering for obesity-induced osteoarthritis: physiology, challenges, and future prospects. J. Orthop. Transl., 2021, 26: 3-15

[160] Al Khatib, F., Gouissem, A., Mbarki, R. & Adouni, M. Biomechanical characteristics of the knee joint during gait in obese versus normal subjects. Int. J. Environ. Res. Public Health 19, 989 (2022).

[161] Zhang, X., Pan, X., Deng, L. & Fu, W. Relationship between Knee Muscle Strength and Fat/Muscle Mass in Elderly Women with Knee Osteoarthritis Based on Dual-Energy X-Ray Absorptiometry. Int. J. Environ. Res. Public Health 17, 573 (2020).

[162] Akamine Y, et al.. Prolonged matrix metalloproteinase-3 high expression after cyclic compressive load on human synovial cells in three-dimensional cultured tissue. Int. J. Oral. Maxillofac. Surg., 2012, 41: 874-881

[163] Yanoshita M, et al.. Cyclic tensile strain upregulates pro-inflammatory cytokine expression Via FAK-MAPK signaling in chondrocytes. Inflammation, 2018, 41: 1621-1630

[164] Hirose N, et al.. Protective effects of cilengitide on inflammation in chondrocytes under excessive mechanical stress. Cell Biol. Int., 2020, 44: 966-974

[165] Shimomura K, et al.. Cyclic compressive loading on 3D tissue of human synovial fibroblasts upregulates prostaglandin E2 via COX-2 production without IL-1β and TNF-α. Bone Jt. Res., 2014, 3: 280-288

[166] Zhang H, et al.. Mechanical overloading promotes chondrocyte senescence and osteoarthritis development through downregulating FBXW7. Ann. Rheum. Dis., 2022, 81: 676-686

[167] Zhu J, Zhu Y, Xiao W, Hu Y, Li Y. Instability and excessive mechanical loading mediate subchondral bone changes to induce osteoarthritis. Ann. Transl. Med., 2020, 8: 350

[168] Wu J, et al.. Axial compressive loading attenuates early osteoarthritis by reducing subchondral bone remodeling. Am. J. sports Med., 2023, 51: 1752-1764

[169] Kovács, B., Vajda, E. & Nagy, E. E. Regulatory effects and interactions of the Wnt and OPG-RANKL-RANK signaling at the bone-cartilage interface in osteoarthritis. Int. J. Mol. Sci. 20, 4653 (2019).

[170] Gløersen M, et al.. Associations of body mass index with pain and the mediating role of inflammatory biomarkers in people with hand osteoarthritis. Arthritis Rheumatol., 2022, 74: 810-817

[171] Junker S, et al.. Expression of adipokines in osteoarthritis osteophytes and their effect on osteoblasts. Matrix Biol., 2017, 62: 75-91

[172] Monika P, Geetha A. The modulating effect of Persea americana fruit extract on the level of expression of fatty acid synthase complex, lipoprotein lipase, fibroblast growth factor-21 and leptin-A biochemical study in rats subjected to experimental hyperlipidemia and obesity. Phytomedicine, 2015, 22: 939-945

[173] Poonpet T, Honsawek S. Adipokines: biomarkers for osteoarthritis?. World J. Orthop., 2014, 5: 319-327,

[174] de Boer TN, et al.. Serum adipokines in osteoarthritis; comparison with controls and relationship with local parameters of synovial inflammation and cartilage damage. Osteoarthr. Cartil., 2012, 20: 846-853

[175] Lambova, S. N. et al. Serum leptin and resistin levels in knee osteoarthritis-clinical and radiologic links: towards precise definition of metabolic type knee osteoarthritis. Biomedicines 9, 1019 (2021).

[176] Min S, et al.. Serum levels of leptin, osteopontin, and sclerostin in patients with and without knee osteoarthritis. Clin. Rheumatol., 2021, 40: 287-294

[177] Kroon FPB, et al.. The role of leptin and adiponectin as mediators in the relationship between adiposity and hand and knee osteoarthritis. Osteoarthr. Cartil., 2019, 27: 1761-1767

[178] Li Z, et al.. Leptin activates RhoA/ROCK pathway to induce cytoskeleton remodeling in nucleus pulposus cells. Int J. Mol. Sci., 2014, 15: 1176-1188

[179] Huang Z, et al.. Articular cartilage regeneration via induced chondrocyte autophagy by sustained release of leptin inhibitor from thermo-sensitive hydrogel through STAT3/REDD1/mTORC1 cascade. Adv. Healthc. Mater., 2023, 12: e2302181

[180] Mutabaruka MS, Aoulad Aissa M, Delalandre A, Lavigne M, Lajeunesse D. Local leptin production in osteoarthritis subchondral osteoblasts may be responsible for their abnormal phenotypic expression. Arthritis Res. Ther., 2010, 12: R20

[181] Presle N, et al.. Differential distribution of adipokines between serum and synovial fluid in patients with osteoarthritis. Contribution of joint tissues to their articular production. Osteoarthr. Cartil., 2006, 14: 690-695

[182] Tang Q, et al.. Association of osteoarthritis and circulating adiponectin levels: a systematic review and meta-analysis. Lipids Health Dis., 2018, 17 189

[183] Lee YH, Song GGJJORD. Association between circulating adiponectin levels and osteoarthritis: A meta-analysis. J Rheum. Dis., 2018, 25: 231-238

[184] Laurberg TB, et al.. Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naive compared with patients with osteoarthritis and controls. J. Rheumatol., 2009, 36: 1885-1891

[185] Orellana C, et al.. Synovial adiponectin was more associated with clinical severity than synovial leptin in women with knee osteoarthritis. Cartilage, 2021, 13: 1675s-1683s

[186] Kang EH, et al.. Adiponectin is a potential catabolic mediator in osteoarthritis cartilage. Arthritis Res. Ther., 2010, 12: R231

[187] Conde J, et al.. Adiponectin and leptin induce VCAM-1 expression in human and murine chondrocytes. PLoS One, 2012, 7: e52533

[188] Francin PJ, et al.. Association between adiponectin and cartilage degradation in human osteoarthritis. Osteoarthr. Cartil., 2014, 22: 519-526

[189] Alissa EM, Alzughaibi LS, Marzouki ZM. Relationship between serum resistin, body fat and inflammatory markers in females with clinical knee osteoarthritis. Knee, 2020, 27: 45-50

[190] Calvet J, et al.. Synovial fluid adipokines are associated with clinical severity in knee osteoarthritis: a cross-sectional study in female patients with joint effusion. Arthritis Res. Ther., 2016, 18: 207

[191] Han W, et al.. Higher serum levels of resistin are associated with knee synovitis and structural abnormalities in patients with symptomatic knee osteoarthritis. J. Am. Med. Dir. Assoc., 2019, 20: 1242-1246

[192] Chen, W. C. et al. Resistin enhances vcam-1 expression and monocyte adhesion in human osteoarthritis synovial fibroblasts by inhibiting mir-381 expression through the pkc, p38, and jnk signaling pathways. Cells 9, 1369 (2020).

[193] Zhang Z, et al.. Resistin induces expression of proinflammatory cytokines and chemokines in human articular chondrocytes via transcription and messenger RNA stabilization. Arthritis Rheum., 2010, 62: 1993-2003

[194] Richter M, Trzeciak T, Owecki M, Pucher A, Kaczmarczyk J. The role of adipocytokines in the pathogenesis of knee joint osteoarthritis. Int. Orthop., 2015, 39: 1211-1217

[195] Wu, M. H., Tsai, C. H., Huang, Y. L., Fong, Y. C. & Tang, C. H. Visfatin promotes IL-6 and TNF-α production in human synovial fibroblasts by repressing miR-199a-5p through ERK, p38 and JNK signaling pathways. Int. J. Mol. Sci. 19, 190 (2018).

[196] Duan Y, et al.. Increased synovial fluid visfatin is positively linked to cartilage degradation biomarkers in osteoarthritis. Rheumatol. Int., 2012, 32: 985-990

[197] Laiguillon MC, et al.. Expression and function of visfatin (Nampt), an adipokine-enzyme involved in inflammatory pathways of osteoarthritis. Arthritis Res. Ther., 2014, 16: R38

[198] Moschen AR, et al.. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J. Immunol., 2007, 178: 1748-1758

[199] Iannone F, Lapadula G. Chemerin/ChemR23 pathway: a system beyond chemokines. Arthritis Res. Ther., 2011, 13: 104

[200] Berg V, et al.. Human articular chondrocytes express ChemR23 and chemerin; ChemR23 promotes inflammatory signalling upon binding the ligand chemerin(21-157). Arthritis Res. Ther., 2010, 12: R228

[201] Recinella L, et al.. Adipokines: new potential therapeutic target for obesity and metabolic, rheumatic, and cardiovascular diseases. Front. Physiol., 2020, 11: 578966

[202] Ko CY, et al.. Omentin-1 ameliorates the progress of osteoarthritis by promoting IL-4-dependent anti-inflammatory responses and M2 macrophage polarization. Int. J. Biol. Sci., 2023, 19: 5275-5289

[203] Cho, B. W. et al. Cross-sectional association between hypercholesterolemia and knee pain in the elderly with radiographic knee osteoarthritis: data from the Korean National Health and Nutritional Examination Survey. J. Clin. Med. 10, 933 (2021).

[204] Triantaphyllidou IE, et al.. Perturbations in the HDL metabolic pathway predispose to the development of osteoarthritis in mice following long-term exposure to western-type diet. Osteoarthr. Cartil., 2013, 21: 322-330

[205] Maddah S, Mahdizadeh J. Association of metabolic syndrome and its components with knee osteoarthritis. Acta Med. Iran., 2015, 53: 743-748

[206] Ertürk C, Altay MA, Bilge A, Çelik H. Is there a relationship between serum ox-LDL, oxidative stress, and PON1 in knee osteoarthritis?. Clin. Rheumatol., 2017, 36: 2775-2780

[207] Farnaghi S, et al.. Protective effects of mitochondria-targeted antioxidants and statins on cholesterol-induced osteoarthritis. FASEB J., 2017, 31: 356-367

[208] Kim K, et al.. RORα controls hepatic lipid homeostasis via negative regulation of PPARγ transcriptional network. Nat. Commun., 2017, 8 162

[209] Choi WS, et al.. The CH25H-CYP7B1-RORα axis of cholesterol metabolism regulates osteoarthritis. Nature, 2019, 566: 254-258

[210] Gentili C, Tutolo G, Pianezzi A, Cancedda R, Descalzi Cancedda F. Cholesterol secretion and homeostasis in chondrocytes: a liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein A1 expression. Matrix Biol., 2005, 24: 35-44

[211] Liang T, et al.. Inhibition of nuclear receptor RORα attenuates cartilage damage in osteoarthritis by modulating IL-6/STAT3 pathway. Cell Death Dis., 2021, 12 886

[212] Chang HW, et al.. Blue Mussel (Mytilus edulis) water extract ameliorates inflammatory responses and oxidative stress on osteoarthritis in obese rats. J. Pain. Res., 2020, 13: 1109-1119

[213] Ma H, et al.. Myriocin alleviates Oleic/Palmitate induced chondrocyte degeneration via the suppression of ceramide. Eur. Rev. Med. Pharmacol. Sci., 2020, 24: 12938-12947

[214] Van de Vyver A, et al.. Synovial fluid fatty acid profiles differ between osteoarthritis and healthy patients. Cartilage, 2020, 11: 473-478

[215] Bastiaansen-Jenniskens YM, et al.. Monounsaturated and saturated, but not n-6 polyunsaturated fatty acids decrease cartilage destruction under inflammatory conditions: a preliminary study. Cartilage, 2013, 4: 321-328

[216] Loef M, et al.. The association of plasma fatty acids with hand and knee osteoarthritis: the NEO study. Osteoarthr. Cartil., 2020, 28: 223-230

[217] Sibille KT, et al.. Omega-6: Omega-3 PUFA ratio, pain, functioning, and distress in adults with knee pain. Clin. J. Pain., 2018, 34: 182-189

[218] Huang MJ, et al.. Enhancement of the synthesis of n-3 PUFAs in fat-1 transgenic mice inhibits mTORC1 signalling and delays surgically induced osteoarthritis in comparison with wild-type mice. Ann. Rheum. Dis., 2014, 73: 1719-1727

[219] Zainal Z, et al.. Relative efficacies of omega-3 polyunsaturated fatty acids in reducing expression of key proteins in a model system for studying osteoarthritis. Osteoarthr. Cartil., 2009, 17: 896-905

[220] Loef M, Schoones JW, Kloppenburg M, Ioan-Facsinay A. Fatty acids and osteoarthritis: different types, different effects. Jt. Bone Spine, 2019, 86: 451-458

[221] Wu CL, Kimmerling KA, Little D, Guilak F. Serum and synovial fluid lipidomic profiles predict obesity-associated osteoarthritis, synovitis, and wound repair. Sci. Rep., 2017, 7 44315

[222] Sokolove J, Lepus CM. Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations. Therapeutic Adv. Musculoskelet. Dis., 2013, 5: 77-94

[223] Nishimura S, et al.. Oxidized low-density lipoprotein (ox-LDL) binding to lectin-like ox-LDL receptor-1 (LOX-1) in cultured bovine articular chondrocytes increases production of intracellular reactive oxygen species (ROS) resulting in the activation of NF-kappaB. Osteoarthr. Cartil., 2004, 12: 568-576

[224] Simopoulou T, Malizos KN, Tsezou A. Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) expression in human articular chondrocytes. Clin. Exp. Rheumatol., 2007, 25: 605-612

[225] Kanata S, et al.. Oxidized LDL binding to LOX-1 upregulates VEGF expression in cultured bovine chondrocytes through activation of PPAR-gamma. Biochem. Biophys. Res. Commun., 2006, 348: 1003-1010

[226] Hashimoto, K. & Akagi, M. The role of oxidation of low-density lipids in pathogenesis of osteoarthritis: A narrative review. J. Int. Med. Res. 48, 300060520931609 (2020).

[227] van den Bosch MHJ, van Lent P, van der Kraan PM. Identifying effector molecules, cells, and cytokines of innate immunity in OA. Osteoarthr. Cartil., 2020, 28: 532-543

[228] Sohn DH, et al.. Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4. Arthritis Res. Ther., 2012, 14: R7

[229] Moradi B, et al.. Unicompartmental and bicompartmental knee osteoarthritis show different patterns of mononuclear cell infiltration and cytokine release in the affected joints. Clin. Exp. Immunol., 2015, 180: 143-154

[230] Sun AR, et al.. Obesity-associated metabolic syndrome spontaneously induces infiltration of pro-inflammatory macrophage in synovium and promotes osteoarthritis. PLoS One, 2017, 12: e0183693

[231] Wang P, Zhu F, Konstantopoulos K. Prostaglandin E2 induces interleukin-6 expression in human chondrocytes via cAMP/protein kinase A- and phosphatidylinositol 3-kinase-dependent NF-kappaB activation. Am. J. Physiol. Cell Physiol., 2010, 298: C1445-1456,

[232] Porée B, et al.. Interleukin-6 (IL-6) and/or soluble IL-6 receptor down-regulation of human type II collagen gene expression in articular chondrocytes requires a decrease of Sp1.Sp3 ratio and of the binding activity of both factors to the COL2A1 promoter. J. Biol. Chem., 2008, 283: 4850-4865

[233] Mengshol JA, Vincenti MP, Coon CI, Barchowsky A, Brinckerhoff CE. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum., 2000, 43: 801-811

[234] Martel-Pelletier J, et al.. The interleukin-1 receptor in normal and osteoarthritic human articular chondrocytes. Identification as the type I receptor and analysis of binding kinetics and biologic function. Arthritis Rheum., 1992, 35: 530-540

[235] Chadjichristos C, et al.. Sp1 and Sp3 transcription factors mediate interleukin-1 beta down-regulation of human type II collagen gene expression in articular chondrocytes. J. Biol. Chem., 2003, 278: 39762-39772

[236] Shakibaei M, Schulze-Tanzil G, John T, Mobasheri A. Curcumin protects human chondrocytes from IL-l1beta-induced inhibition of collagen type II and beta1-integrin expression and activation of caspase-3: an immunomorphological study. Ann. Anat., 2005, 187: 487-497

[237] Stöve J, Huch K, Günther KP, Scharf HP. Interleukin-1beta induces different gene expression of stromelysin, aggrecan and tumor-necrosis-factor-stimulated gene 6 in human osteoarthritic chondrocytes in vitro. Pathobiology, 2000, 68: 144-149

[238] Nietfeld JJ, Wilbrink B, Den Otter W, Huber J, Huber-Bruning O. The effect of human interleukin 1 on proteoglycan metabolism in human and porcine cartilage explants. J. Rheumatol., 1990, 17: 818-826

[239] Na HS, et al.. Interleukin-1-Interleukin-17 signaling axis induces cartilage destruction and promotes experimental osteoarthritis. Front. Immunol., 2020, 11: 730

[240] Senter R, et al.. Efficacy and Safety of FX201, a Novel Intra-Articular IL-1Ra gene therapy for osteoarthritis treatment, in a rat model. Hum. Gene Ther., 2022, 33: 541-549

[241] Verbruggen G, Wittoek R, Vander Cruyssen B, Elewaut D. Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification. Ann. Rheum. Dis., 2012, 71: 891-898

[242] Guss JD, et al.. The effects of metabolic syndrome, obesity, and the gut microbiome on load-induced osteoarthritis. Osteoarthr. Cartil., 2019, 27: 129-139

[243] Zhao YP, et al.. Progranulin protects against osteoarthritis through interacting with TNF-α and β-Catenin signalling. Ann. Rheum. Dis., 2015, 74: 2244-2253

[244] Li J, et al.. Metformin limits osteoarthritis development and progression through activation of AMPK signalling. Ann. Rheum. Dis., 2020, 79: 635-645

[245] Guerne PA, Carson DA, Lotz M. IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro. J. Immunol., 1990, 144: 499-505

[246] Grunke M, Schulze-Koops H. Successful treatment of inflammatory knee osteoarthritis with tumour necrosis factor blockade. Ann. Rheum. Dis., 2006, 65: 555-556

[247] Chevalier X, et al.. Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: a randomised, multicentre, double-blind, placebo-controlled trial. Ann. Rheum. Dis., 2015, 74: 1697-1705

[248] Tsuchida AI, et al.. Cytokine profiles in the joint depend on pathology, but are different between synovial fluid, cartilage tissue and cultured chondrocytes. Arthritis Res. Ther., 2014, 16: 441

[249] Kugisaki H, et al.. Serum concentrations of interleukin-6 in patients following unilateral versus bilateral total knee arthroplasty. J. Orthop. Sci. Off. J. Jpn. Orthop. Assoc., 2009, 14: 437-442

[250] Livshits G, et al.. Interleukin-6 is a significant predictor of radiographic knee osteoarthritis: the chingford study. Arthritis Rheum., 2009, 60: 2037-2045

[251] Ryu JH, et al.. Interleukin-6 plays an essential role in hypoxia-inducible factor 2α-induced experimental osteoarthritic cartilage destruction in mice. Arthritis Rheum., 2011, 63: 2732-2743

[252] Wiegertjes R, van de Loo FAJ, Blaney Davidson EN. A roadmap to target interleukin-6 in osteoarthritis. Rheumatology, 2020, 59: 2681-2694

[253] Nasi S, So A, Combes C, Daudon M, Busso N. Interleukin-6 and chondrocyte mineralisation act in tandem to promote experimental osteoarthritis. Ann. Rheum. Dis., 2016, 75: 1372-1379

[254] Latourte A, et al.. Systemic inhibition of IL-6/Stat3 signalling protects against experimental osteoarthritis. Ann. Rheum. Dis., 2017, 76: 748-755

[255] Richette P, et al.. Efficacy of tocilizumab in patients with hand osteoarthritis: double blind, randomised, placebo-controlled, multicentre trial. Ann. Rheum. Dis., 2021, 80: 349-355

[256] Parhofer KG. The treatment of disorders of lipid metabolism. Dtsch. Arztebl. Int., 2016, 113: 261-268

[257] Haj-Mirzaian A, et al.. Statin use and knee osteoarthritis outcome measures according to the presence of heberden nodes: results from the osteoarthritis initiative. Radiology, 2019, 293: 396-404

[258] Clockaerts S, et al.. Statin use is associated with reduced incidence and progression of knee osteoarthritis in the Rotterdam study. Ann. Rheum. Dis., 2012, 71: 642-647

RIGHTS & PERMISSIONS

The Author(s)